Skip to content
Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.
Powered by THEMA

Baker Capital Strategies

Free Registration

Register for access to news, tools, alerts and reports.

THEMA Basic included at launch.

Use at least 8 characters.

Home/The Filing Wire/Eton Pharmaceuticals, Inc./ 10-Q

Quarterly Report · 10-Q

Eton Pharmaceuticals, Inc.

ETONNASDAQEQUITYCurrent

Quarterly Report

Filed Aug 13, 2026Accepted Aug 13, 2026, 4:16 PM EDTCIK 1710340Accession 0001437749-26-027684
View company →Permanent SEC source ↗
Share

Company context

Current securities

ETONNASDAQ · EQUITY · Current

Recent company filings

  1. 4/A filingAug 31, 2026
  2. 4 filingAug 28, 2026
  3. 144 filingAug 28, 2026
  4. 4 filingAug 24, 2026
  5. 144 filingAug 24, 2026

As-filed source

Primary evidence
As filedOpen full document ↗